Vivos Inc., a pharmaceutical
company in the process of researching and developing minimally invasive treatments to combat cancer has developed an Yttrium-90 based brachytherapy injectable device, for the treatment of
tumors in animals (IsoPet®) and in humans (RadioGel™). Brachytherapy uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope
directly inside the treatment area using the company’s proprietary hydrogel formulation.